Last data update: Apr 22, 2024. (Total: 46599 publications since 2009)
Records 1-3 (of 3 Records) |
Query Trace: Thompson BL [original query] |
---|
Cardiopulmonary impact of particulate air pollution in high-risk populations: JACC State-of-the-Art Review
Newman JD , Bhatt DL , Rajagopalan S , Balmes JR , Brauer M , Breysse PN , Brown AGM , Carnethon MR , Cascio WE , Collman GW , Fine LJ , Hansel NN , Hernandez A , Hochman JS , Jerrett M , Joubert BR , Kaufman JD , Malik AO , Mensah GA , Newby DE , Peel JL , Siegel J , Siscovick D , Thompson BL , Zhang J , Brook RD . J Am Coll Cardiol 2020 76 (24) 2878-2894 Fine particulate air pollution <2.5 μm in diameter (PM(2.5)) is a major environmental threat to global public health. Multiple national and international medical and governmental organizations have recognized PM(2.5) as a risk factor for cardiopulmonary diseases. A growing body of evidence indicates that several personal-level approaches that reduce exposures to PM(2.5) can lead to improvements in health endpoints. Novel and forward-thinking strategies including randomized clinical trials are important to validate key aspects (e.g., feasibility, efficacy, health benefits, risks, burden, costs) of the various protective interventions, in particular among real-world susceptible and vulnerable populations. This paper summarizes the discussions and conclusions from an expert workshop, Reducing the Cardiopulmonary Impact of Particulate Matter Air Pollution in High Risk Populations, held on May 29 to 30, 2019, and convened by the National Institutes of Health, the U.S. Environmental Protection Agency, and the U.S. Centers for Disease Control and Prevention. |
Advancing legal epidemiology: An introduction
Thompson BL , Cloud LK , Gable L . J Public Health Manag Pract 2020 26 Suppl 2 S1-s3 Chronic and noncommunicable health conditions, including heart disease, stroke, diabetes, hypertension, cancer, and asthma, are leading causes of death and disability in the United States, with 2 in 5 adults afflicted with multiple conditions.1,2 Deaths from heart disease are increasing in the majority of counties.3 While deaths from stroke had been declining for decades, decreases in stroke deaths have stalled in the majority of states since 2013.4 In addition, individuals with lower socioeconomic status and those who identify as members of racial and ethnic minority groups experience higher rates of chronic diseases, less access to quality health care, and worse health outcomes.5–7 The effects of chronic and noncommunicable conditions also extend far beyond health outcomes. Direct costs of treating chronic conditions and indirect costs including loss of productivity amount to an estimated $3.7 trillion.8 |
Privileging the preventive medicine physician: A solution in search of a problem
Thompson BL . Prev Med 2019 118 352-353 As a preventive medicine physician, I appreciate the concern that Drs. Jung and Lushniak have shown for the future of our specialty (Jung and Lushniak, 2019; Jung and Lushniak, 2018; Jung and Lushniak 2017). They have raised critical concerns about the specialty of preventive medicine and helped to draw attention to a field of medicine that is too often overlooked. However, However, I find some aspects of their article in this issue concerning. |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source:
- Powered by CDC PHGKB Infrastructure